Anavex Life Sciences Corp (AVXL): “Although this is an open label study wi...

Reply Private New

Replies (3) Next 10 Prev Next

Send PM Follow Ignore

Followers	5
Posts	557
Boards Moderated	0
Alias Born	06/23/2015

nobrainerstocks

Re: OFP post# 113298

Sunday, 07/30/2017 11:23:43 AM

Sunday, July 30, 2017 11:23:43 AM

“Although this is an open label study with 32 patients, I have never seen mild-to-moderate Alzheimer’s patients maintain near baseline cognitive and activities of daily living function and positive correlation with all other measures over a 41-week trial period in any prior study with an approved or experimental drug. It is quite plausible that complex CNS diseases like Alzheimer’s may require a comprehensive approach, including restoration of cellular homeostasis.” - George Perry, PhD, Dean and Professor at the University of Texas at San Antonio and Editor-in Chief of the Journal of Alzheimer’s Disease.

How about good old Earn Heaven, is he just making things up and telling stories too?

https://www.facebook.com/TheProjectTV/videos/10154154448498441/?hc_ref=SEARCH

A cure for Alzheimer's: a fantasy, a wish, an impossible dream; the same words that were said to Galileo, Edison, Curie, Salk and whoever dreamed up the internet. Yesterday's dream is today's reality. - Trish Vradenburg"